Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 739 clinical trials
Featured trial
Performance of CAD/CAM Milled and 3D-printed Full-arch Implant-supported Provisionals Restorations

  • Optical properties, initial color, and degradation of the materials used
  • ul>

    Accepts healthy volunteers
    • 0 views
    • 18 Feb, 2026
    • 1 location
    Efficacy of Customized Zirconia Sheet vs PTFE as a Non-resorbable Barrier in Maxillary Alveolar Ridge Augmentation

  • the accuracy of using two software in the designing of the zircon membrane? <ul>
  • Participants will be selected according to the inclusion criteria of the study, having a defect in the upper jaw that prevent rehabilitation of the jaw.
  • Accepts healthy volunteers
    Online studies
    • 0 views
    • 29 Jan, 2024
    • 1 location
    • Online study
    Moisturizer Containing Licochalcone A, Decanediol, L-carnitine and Salicylic Acid in Reducing Relapsing of Acne

    Moisturizer containing the active ingredients of licochalcone A, decanediol, L-carnitine, and salicylic acid may be beneficial in alternative treatment of acne in maintenance phase. This study aims to evaluate the efficacy and safety of moisturizer containing the active ingredients of licochalcone A, decanediol, L-carnitine, and salicylic acid during the maintenance …

    Online studies
    • 0 views
    • 14 Nov, 2025
    • 1 location
    • Online study
    Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)  

    The Swiss-Ped-IBrainD is a national patient registry that collects information on diagnosis, symptoms, treatment, and follow-up of pediatric patients with an inflammatory brain disease in Switzerland. It was first implemented in 2020 in the pediatric clinic of the university hospital in Bern. Further centers all over Switzerland were opened for …

    neuromyelitis optica
    optic neuritis
    myelitis
    multiple sclerosis
    Online studies
    • 0 views
    • 14 Mar, 2022
    • 1 location
    • Online study
    • 0 views
    • 04 Dec, 2020
    • 7 locations
    SAR408701 Versus Docetaxel in Previously Treated Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients

  • The primary objective is to determine whether SAR408701 improves the overall survival (OS) when compared with docetaxel in participants with metastatic non-squamous NSCLC expressing CEACAM5 2+ in intensity in at least 50% of the tumor cell population and previously treated with standard-of-care platinum-based chemotherapy and an immune checkpoint inhibitor.
  • ul>

    metastasis
    pulmonary metastasis
    non-small cell lung cancer
    measurable disease
    small cell lung cancer
    • 0 views
    • 04 Dec, 2020
    • 169 locations
    SAR408701 Versus Docetaxel in Previously Treated Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients  

  • The primary objective is to determine whether SAR408701 improves the overall survival (OS) when compared with docetaxel in participants with metastatic non-squamous NSCLC expressing CEACAM5 2+ in intensity in at least 50% of the tumor cell population and previously treated with standard-of-care platinum-based chemotherapy and an immune checkpoint inhibitor.
  • ul>

    metastasis
    pulmonary metastasis
    non-small cell lung cancer
    measurable disease
    small cell lung cancer
    • 0 views
    • 21 Dec, 2020
    • 52 locations
    Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)

    Primary Objective:

    <ul>
  • To evaluate the efficacy of treatment with dupilumab to reduce sinus opacification in a population with allergic fungal rhinosinusitis (AFRS)
  • ul>

    Secondary Objectives:

    <ul>
  • To evaluate the efficacy of treatment with dupilumab to reduce sinus opacification in a population with allergic fungal rhinosinusitis (AFRS) at Week 24 …

    • 0 views
    • 27 Sep, 2023
    • 30 locations
    A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

    Eligible participants will be randomized in a 1:1 ratio to receive one of the following treatment regimens during induction phase:-

    <ul>
  • Arm A: Tiragolumab plus atezolizumab and CE
  • Arm B: Placebo plus atezolizumab and CE
  • ul>

    Following the induction phase, participants will continue maintenance therapy with either atezolizumab …

    measurable disease
    carboplatin
    small cell lung cancer
    extensive stage sclc
    etoposide
    • 0 views
    • 16 Feb, 2024
    • 147 locations
    Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa (Baby-COMET)

  • Treatment duration: Up to 4 years
  • Visit frequency: every other week and potentially every week
  • ul>

    • 0 views
    • 19 Jul, 2024
    • 4 locations